one-year survival increased from 49 % in the first program to 62 % in the second for all stroke patients , from 54 % to 68 % for patients with cerebral infarction , and from 18 % to 55 % for patients with cerebral hemorrhage .
C0038454
stroke
C2937358
cerebral hemorrhage